Search results
Newbridge Financial Services Group Inc. Reduces Stock Position in iShares Biotechnology ETF...
ETF DAILY NEWS· 17 hours agoNewbridge Financial Services Group Inc. lessened its stake in shares of iShares Biotechnology ETF (NASDAQ:IBB – Free Report) by 19.8% during the fourth quarter, according ...
Puma biotechnology executive sells $89.8k in stock By Investing.com
Investing.com· 2 days agoAdrian Senderowicz, a director at Puma Biotechnology, Inc. (NASDAQ:PBYI), has sold a total of 27,000...
Puma Biotechnology director sells shares worth over $37,000 By Investing.com
Investing.com· 2 days agoIn a recent transaction, Allison Dorval, a director at Puma Biotechnology, Inc. (NASDAQ:PBYI), has...
Roche (RHHBY), Ascidian Team Up for RNA Exon Editing Therapeutics
Zacks via Yahoo Finance· 7 hours agoRoche (RHHBY) gets exclusive, target-specific rights to Ascidian's RNA exon editing technology for...
Is Vir Biotechnology (NASDAQ:VIR) In A Good Position To Deliver On Growth Plans?
Simply Wall St. via Yahoo Finance· 2 days agoNonetheless, only a fool would ignore the risk that a loss making company burns through its cash too...
Guggenheim Initiates Coverage on Repligen (NASDAQ:RGEN)
ETF DAILY NEWS· 21 hours agoThe firm issued a neutral rating on the biotechnology company’s stock. JPMorgan Chase & Co. dropped their target price on shares of Repligen from $230.00 to $200.00 and set ...
1,701 Shares in Axon Enterprise, Inc. (NASDAQ:AXON) Purchased by Virtu Financial LLC
ETF DAILY NEWS· 19 hours ago(NASDAQ:AXON – Free Report) in the 4th quarter, according to the company in its most recent filing...
Scientist.com Unveils Elisa: An LLM-Powered Research Assistant for Scientists in the Pharmaceutical...
Morningstar· 12 hours agoScientist.com, the world’s leading marketplace for biopharma research, today announced the launch of a new large language model (LLM)-powered research assistant called Elisa, named in homage ...
Vir Biotechnology (NASDAQ:VIR) Trading Down 5.5%
ETF DAILY NEWS· 4 days agoShares of Vir Biotechnology, Inc. (NASDAQ:VIR – Get Free Report) dropped 5.5% during trading on Friday . Approximately 272,073 shares traded hands during mid-day trading, ...
Marea launches with $190m to develop cardiometabolic therapies
Pharmaceutical Technology via Yahoo Finance· 14 hours agoClinical-stage biotechnology company Marea Therapeutics has launched with funding of $190m secured...